A draft text of the WTO TRIPS Waiver, which is designed to facilitate production of Covid-19 medicines in developing countries, has language that could exclude China from its scope. At a WTO meeting on Friday, China raised objections to specific aspects of that language.
This post is for subscribers only
Already have an account? Sign in
You've successfully subscribed to China Trade Monitor
Great! Next, complete checkout for full access to China Trade Monitor
Welcome back! You've successfully signed in.
Unable to sign you in. Please try again.
Success! Your account is fully activated, you now have access to all content.
Error! Stripe checkout failed.
Success! Your billing info is updated.
Error! Billing info update failed.